查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1623502

全球除颤器市场规模（按最终用户、产品、地区、范围和预测）

Global Defibrillators Market Size By End User(Hospitals, Clinics, & Cardiac Centers, Pre-Hospitals, Public Access Markets), By Product(Implantable Cardioverter Defibrillators (ICDS), External Defibrillators), By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3个工作天内

价格
简介目录

去颤器市场规模及预测

2020 年，除颤器市场规模价值为 108.8 亿美元，预计到 2028 年将达到 167.2 亿美元，2021 年至 2028 年的复合年增长率为 5.60%。

老年人口的增加（老年人患目标疾病的风险最高）、心臟病发病率的上升以及对提供公共除颤器的日益关注，预计将在预测年内推动除颤器市场的发展。颤器市场将受到拖曳。全球除颤器市场报告对市场进行了全面的评估。它对关键细分市场、趋势、市场推动因素、阻碍因素、竞争格局以及在市场中发挥关键作用的因素进行了全面的分析。

去颤器市场的定义

去颤器是一种电子设备，用于在无脉性室性心动过速、心律不整和心室颤动等严重情况下向患者心臟提供治疗性电击。电击使心肌去极化，恢復正常的电脉衝。它可以预防患有危及生命的心律不整的人的猝死。除颤器的最终用户包括医院、诊所、心臟中心、院前急救、公共市场、家庭保健和替代医学市场。依产品不同，分为植入式心臟復律去颤器 (ICD)、体外去颤器、手动体外去颤器和可穿戴式心臟復律去颤器 (WCD)。

全球除颤器市场概况

老年人口的增加（目标疾病的风险最高）和对提供公共场所除颤器的日益关注预计将在预测几年内推动除颤器市场的发展。此外，有关除颤器和心臟病发病率上升的培训和宣传计划预计将在未来几年推动市场发展。此外，CRT-D、S-ICD 和 MRI 相容 ICD 的开发也正在取得进展。

也有一些限制和课题阻碍了市场的成长。缺乏对心臟骤停（SCA）的认识和产品缺陷等因素可能成为市场发展的阻碍因素。

目录

第 1 章：全球除颤器市场简介

    市场概况
  • 研究范围
  • 先决条件

第 2 章执行摘要

第 3 章：经过验证的市场研究方法

  • 资料探勘
  • 验证
  • 主要来源
  • 资料来源列表

第 4 章：全球除颤器市场展望

  • 概述
  • 市场动态
    • 驱动程式
    • 阻碍因素
    • 机会
  • 波特五力模型
  • 价值链分析
  • 监理框架

第5章 全球除颤器市场（依最终用户划分）

  • 医院、诊所和心臟中心
  • 院前
  • 公共接取市场
  • 家庭医疗保健
  • 替代医学市场
第6章 全球除颤器市场依产品类型
  • 植入式心臟復律去颤器 (ICD)
    • 植入式心臟復律去颤器 (T-ICD)
    • 皮下植入式心臟復律去颤器 (S-ICD)
  • 体外去颤器
    • 自动体外心臟去颤器 (AED)
  • 手动体外心臟去颤器
  • 穿戴式心臟復律去颤器 (WCD)

第7章 全球除颤器市场（按地区）

  • 概述
  • 2012 年至 2025 年北美市场估计与预测
    • 美国
    • 加拿大
    • 墨西哥
  • 2012 年至 2025 年欧洲市场估计与预测
    • 德国
    • 英国
    • 法国
    • 其他欧洲国家
  • 2012 年至 2025 年亚太市场估计与预测
    • 中国
    • 日本
    • 印度
    • 其他亚太地区
  • 2012 年至 2025 年拉丁美洲市场估计与预测
    • 巴西
    • 阿根廷
  • 2012 年至 2025 年世界其他地区市场估计与预测

第 8 章全球除颤器市场竞争格局

  • 概述
  • 公司市占率
  • 供应商概况
  • 主要发展策略

第9章 公司简介

  • Medtronic PLC
  • St. Jude Medical, Inc.
  • Boston Scientific Corporation
  • Philips Healthcare
  • Zoll Medical Corporation
  • Biotronik Se & Co.Kg
  • Physio-Control International, Inc.
  • Cardiac Science Corporation
  • Sorin Group
  • Nihon Kohden Corporation

第10章 附录

  • 关联报告
简介目录
Product Code: 23941

Defibrillators Market Size And Forecast

Defibrillators Market size was valued at USD 10.88 Billion in 2020 and is projected to reachUSD 16.72 Billion by 2028, growing at aCAGR of 5.60% from 2021 to 2028.

The growing geriatric population having the highest risk of target diseases, rising incidence of cardiac diseases, and increasing focus on providing public-access defibrillators are expected to drive the defibrillators market over the predicted years. The Global Defibrillators Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Defibrillators Market Definition

A defibrillator is an electronic device used to deliver a therapeutic shock to a patient's heart in serious conditions like pulseless ventricular tachycardia, cardiac arrhythmia, and ventricular fibrillation. The electric shock depolarizes the heart muscles and restores its normal electric impulse. It can prevent sudden death among people suffering from life-threatening arrhythmia. End-Users of defibrillators are Hospitals, Clinics, & Cardiac Centers, Pre-Hospitals, Public Access Markets, Home Care, and Alternate Care Markets. Based on the product, they are classified into Implantable Cardioverter Defibrillators (ICDS), External Defibrillators, Manual External Defibrillators, and Wearable Cardioverter Defibrillators (WCDS).

Global Defibrillators Market Overview

The growing geriatric population having the highest risk of target diseases and increasing focus on providing public-access defibrillators are expected to drive the defibrillators market over the predicted years. Also, training & awareness programs on defibrillators and the rising incidence of cardiac diseases expects a boost to the market in the coming years. Additionally, the development of CRT-Ds, S-ICDs, and MRI-compatible ICDs

There are certain restraints and challenges faced which can hinder the market growth. Factors such as lack of awareness about the sudden cardiac arrest (SCA) and product failures are likely to act as market restraints.

Global Defibrillators Market: Segmentation Analysis

The Global Defibrillators Market is Segmented into End User, Product, And Geography.

Defibrillators Market by End-User

Hospitals, Clinics, & Cardiac Centers

Pre-Hospitals

Home Care

Alternate Care Markets

Based on the end-user, the market is bifurcated into Hospitals, Clinics, & Cardiac Centers, Pre-Hospitals, Public Access Markets, Home Care, and Alternate Care Markets. The Hospitals, Clinics, & Cardiac Centers segment is predicted to hold the largest market share. The factors can be attributed to the availability of reimbursements facilities and upsurge in the number of cardiac implant procedures.

Defibrillators Market by Product

Implantable Cardioverter Defibrillators (ICDS)

Implantable Cardioverter Defibrillators (T-ICDS)

Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)

Dual-Chamber ICDS

Single-Chamber ICDS

Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)

External Defibrillators

Automated External Defibrillators (AEDS)

Semi-Automated External Defibrillators

Fully Automated External Defibrillators

Manual External Defibrillators

Wearable Cardioverter Defibrillators (WCDS)

Based on the product, the market is bifurcated into Implantable Cardioverter Defibrillators (ICDS), External Defibrillators, Manual External Defibrillators, and Wearable Cardioverter Defibrillators (WCDS). The Implantable Cardioverter Defibrillators (ICDS) segment is anticipated to have the highest CAGR in the forecasted period. The factors can be attributed to the rising adoption of cardiac resynchronization therapy defibrillators (CRT-Ds) & S-ICD systems across the globe and the development of technologically advanced devices with extended longevity.

Defibrillators Market by Geography

Based on regional analysis, the Global Defibrillators Market is classified into

North America

Europe

Asia Pacific

Rest of the world

The largest share in the market will be dominated by North America owing to the technological advancements, increasing the geriatric population, and the prevalence of cardiac diseases in this region.

Key Players

The Major Players in the market are as follows:

  • Medtronic PLC
  • St. Jude Medical, Inc.
  • Boston Scientific Corporation
  • Philips Healthcare (A Division of Koninklijke Philips N.V.)
  • Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation)
  • Biotronik Se & Co.Kg
  • Physio-Control International, Inc.
  • Cardiac Science Corporation (A Portfolio Company of Aurora Capital Group)
  • orin Group (Now Livanova PLC)
  • Nihon Kohden Corporation

These Major Players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.

Key Developments

Product Launches and Product Expansions

  • On April 2020, Philips, a health technology company, announced that the Emergency Care and Resuscitation (ECR) business is recommencing the US manufacturing and shipping of external defibrillators. The company notified that the US Food and Drug Administration (FDA) had lifted the restrictions imposed on the manufacturing and distribution of defibrillators in the US.
  • On March 2021, The Rankin government announced that all public schools in Nova Scotia would be provided automated external defibrillators. The government invested USD 700,000. The purpose of this investment is the availability of these devices at the time of cardiac emergency.
  • On July 2021, ZOLL Medical Corporation announced that the company had received clearance from FDA 510(k) to release the TBI Dashboard feature on its Propaq M monitor and Propaq MD defibrillator. This feature provided clinical decision support for managing patients with TBI and was available in international markets, but it is now available in the U.S. market with the FDA clearance.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL DEFIBRILLATORS MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL DEFIBRILLATORS MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis
  • 4.5 Regulatory Framework

5 Global Defibrillators Market, By End User

  • 5.1 Hospitals, Clinics, & Cardiac Centers
  • 5.2 Pre-Hospitals
  • 5.3 Public Access Markets
  • 5.4 Home Care
  • 5.5 Alternate Care Markets

6 Global Defibrillators Market, By Product

  • 6.1 Implantable Cardioverter Defibrillators (ICDS)
    • 6.1.1 Implantable Cardioverter Defibrillators (T-ICDS)
    • 6.1.1.1 Biventricular ICDS/Cardiac Resynchronization Therapy Defibrillators (CRT-DS)
    • 6.1.1.2 Dual-Chamber ICDS
    • 6.1.1.3 Single-Chamber ICDS
    • 6.1.2 Subcutaneous Implantable Cardioverter Defibrillators (S-ICDS)
  • 6.2 External Defibrillators
    • 6.2.1 Automated External Defibrillators (AEDS)
    • 6.2.1.1 Semi-Automated External Defibrillators
    • 6.2.1.2 Fully Automated External Defibrillators
  • 6.3 Manual External Defibrillators
  • 6.4 Wearable Cardioverter Defibrillators (WCDS)

7 GLOBAL DEFIBRILLATORS MARKET, BY GEOGRAPHY

  • 7.1 Overview
  • 7.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
    • 7.2.1 U.S.
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
    • 7.3.1 Germany
    • 7.3.2 U.K.
    • 7.3.3 France
    • 7.3.4 Rest of Europe
  • 7.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
    • 7.4.1 China
    • 7.4.2 Japan
    • 7.4.3 India
    • 7.4.4 Rest of Asia Pacific
  • 7.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
    • 7.5.1 Brazil
    • 7.5.2 Argentina
  • 7.6 Rest of the World Regional Market Estimates and Forecasts, 2012 a€" 2025

8 GLOBAL DEFIBRILLATORS MARKET COMPETITIVE LANDSCAPE

  • 8.1 Overview
  • 8.2 Company Market Share
  • 8.3 Vendor Landscape
  • 8.4 Key Development Strategies

9 COMPANY PROFILES

  • 9.1 Medtronic PLC
    • 9.1.1 Overview
    • 9.1.2 Financial Performance
    • 9.1.3 Product Outlook
    • 9.1.4 Key Developments
  • 9.2 St. Jude Medical, Inc.
    • 9.2.1 Overview
    • 9.2.2 Financial Performance
    • 9.2.3 Product Outlook
    • 9.2.4 Key Developments
  • 9.3 Boston Scientific Corporation
    • 9.3.1 Overview
    • 9.3.2 Financial Performance
    • 9.3.3 Product Outlook
    • 9.3.4 Key Developments
  • 9.4 Philips Healthcare
    • 9.4.1 Overview
    • 9.4.2 Financial Performance
    • 9.4.3 Product Outlook
    • 9.4.4 Key Developments
  • 9.5 Zoll Medical Corporation
    • 9.5.1 Overview
    • 9.5.2 Financial Performance
    • 9.5.3 Product Outlook
    • 9.5.4 Key Developments
  • 9.6 Biotronik Se & Co.Kg
    • 9.6.1 Overview
    • 9.6.2 Financial Performance
    • 9.6.3 Product Outlook
    • 9.6.4 Key Developments
  • 9.7 Physio-Control International, Inc.
    • 9.7.1 Overview
    • 9.7.2 Financial Performance
    • 9.7.3 Product Outlook
    • 9.7.4 Key Developments
  • 9.8 Cardiac Science Corporation
    • 9.8.1 Overview
    • 9.8.2 Financial Performance
    • 9.8.3 Product Outlook
    • 9.8.4 Key Developments
  • 9.9 Sorin Group
    • 9.9.1 Overview
    • 9.9.2 Financial Performance
    • 9.9.3 Product Outlook
    • 9.9.4 Key Developments
  • 9.10 Nihon Kohden Corporation
    • 9.10.1 Overview
    • 9.10.2 Financial Performance
    • 9.10.3 Product Outlook
    • 9.10.4 Key Developments

10 Appendix

  • 10.1 Related Reports